https://pubmed.ncbi.nlm.nih.gov/24463482/?dopt=Abstract
Taxanes, past, present, and future impact on non-small cell lung cancer
Taxanes are novel microtubule-stabilizing agents and have shown efficacy in non-small cell lung cancer (NSCLC) since the 1990s. Paclitaxel and docetaxel have...
past present and future
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.01397/full
Frontiers | Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast...
Breast cancer is the most prevalent type of malignancies in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherape...